Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168K Buy
12,450
+50
+0.4% +$743 ﹤0.01% 1589
2026
Q1
$191K Buy
12,400
+175
+1% +$2.91K ﹤0.01% 1494
2025
Q4
$227K Buy
12,225
+1,600
+15% +$27.5K ﹤0.01% 1385
2025
Q3
$171K Hold
10,625
﹤0.01% 1479
2025
Q2
$116K Buy
10,625
+350
+3% +$3.92K ﹤0.01% 1455
2025
Q1
$128K Buy
+10,275
New +$169K ﹤0.01% 1350

Other funds holding MESO

Choreo LLC's MESO Position: Q2 2026 in Review

Choreo LLC increased its Mesoblast (MESO) stake by 0.4% in Q2 2026, buying an estimated $743 and bringing the position to 12,450 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Choreo LLC first reported a position in MESO in Q1 2025 and has held it in 6 quarters since. The position peaked at $227K in Q4 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Choreo LLC held 12,450 shares of Mesoblast worth $168K as of Q2 2026.
  • Choreo LLC bought 50 Mesoblast shares in Q2 2026, an estimated $743.
  • Mesoblast made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1589 holding.
  • Choreo LLC first reported a position in Mesoblast in Q1 2025 and has held it in 6 quarters since.
  • Choreo LLC's Mesoblast position peaked at $227K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.